VA Caribbean Healthcare System Internal Medicine

Topics

• Multiple Myeloma Research and Treatments 82
• Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 45
• Cell Adhesion Molecules Research 28
• CAR-T cell therapy research 23
• Hepatitis C virus research 23
• Peroxisome Proliferator-Activated Receptors 22
• Hematopoietic Stem Cell Transplantation 18
• Nicotinic Acetylcholine Receptors Study 14
• Alcohol Consumption and Health Effects 11
• Health and Medical Research Impacts 9
• Hepatitis B Virus Studies 9
• Liver Disease Diagnosis and Treatment 7

Most cited

1. Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma.

   Blood · 2025 · 135 citations · Melissa Alsina

2. Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.

   The New England journal of medicine · 2022 · 422 citations · Melissa Alsina

3. Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 271 citations · Melissa Alsina

4. Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 48 citations · Melissa Alsina

5. The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.

   Journal of hematology & oncology · 2023 · 128 citations · Melissa Alsina

6. Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.

   Blood cancer journal · 2023 · 117 citations ·